Dr. Gemunu Hewawitharana is a board-certified Consultant Paediatric Neurologist from Sri Lanka with expertise in Paediatric Neurology, Neurophysiology, and Neurorehabilitation. He graduated from the University of Ruhuna in 2000 with Second Class Honours and a Distinction in Paediatrics, and later completed his MD in Paediatrics at the Postgraduate Institute of Medicine, University of Colombo, in 2008. He pursued advanced training in Paediatric and Adult Neurology at the National Hospital of Sri Lanka and Lady Ridgeway Children’s Hospital in Colombo. He also underwent overseas training in Paediatric Neurology at Great Ormond Street Hospital for Children, London, and University Hospital Bristol in the United Kingdom. He became board-certified as a Paediatric Neurologist in 2011.
Dr. Hewawitharana served as a Consultant Paediatric Neurologist at Teaching Hospital Karapitiya for over a decade (2012–2022). During his tenure, he played a pivotal role in establishing tertiary-level Paediatric Neurology, Neurophysiology, and Neurodisability services in the Southern Province. He was instrumental in developing infrastructure such as video telemetry, visual rehabilitation facilities, and a Child Development Centre.
He also introduced a digital clinical database and a digital patient management platform, enabling electronic prescriptions, digital patient records, telemedicine services, and a regional paediatric neurology network within the Southern Province. His telemedicine initiative provided continuous care for children with neurological conditions and was particularly impactful during the COVID-19 pandemic.
Under his leadership, the Paediatric Neurology Unit at Teaching Hospital Karapitiya was accredited as a postgraduate training centre for Paediatric Neurology, offering hands-on neurology training and organising academic sessions with international experts. He has served as both a trainer and an examiner for the Postgraduate Institute of Medicine (PGIM) and the Faculty of Medicine, University of Ruhuna.
Dr. Hewawitharana is an active member of numerous national and international professional bodies and has received several international scholarships, including from the International League Against Epilepsy (ILAE) and the American Academy for Cerebral Palsy and Developmental Medicine (AACPDM). Beyond clinical duties, he has made significant contributions to research, focusing on early detection and intervention for developmental disorders and neurorehabilitation. He has presented his work at national and international conferences—winning multiple best presentation awards—and has secured research grants. His scholarly contributions include more than 20 peer-reviewed publications in national and international journals.
Early detection of neurodevelopmental delays and cerebral palsy (CP) in high-risk newborns is crucial, as timely intervention can significantly improve motor, cognitive, and social-emotional outcomes. However, in low- and middle-income countries (LMICs), access to advanced diagnostic tools such as MRI and specialised neurological care is often limited due to high costs, geographic barriers, and a shortage of trained professionals. Addressing these challenges, a study conducted at the Paediatric Neurology Unit, Teaching Hospital Karapitiya (THK), Sri Lanka, introduced a low-cost and effective method for early detection of developmental delays and CP.
The study utilised a modified protocol combining two General Movement Assessments (GMAs) and the Hammersmith Infant Neurological Examination (HINE), tailored to the resource limitations of LMICs. The protocol included three key assessments: Writhing Movements Assessment before hospital discharge (prior to 44 weeks of gestation), Fidgety Movements Assessment at 3–4 months corrected age, and HINE at 5–6 months corrected age. The study followed 201 high-risk infants and collected key data on birth histories, risk factors such as prematurity, low birth weight, birth asphyxia, and perinatal infections, along with cerebral palsy diagnoses and developmental assessments using the Bayley Scales of Infant Development (Bayley-4).
By the age of two, 10% of the children were diagnosed with CP, with spastic quadriplegia being the most prevalent subtype (50% of CP cases). Most of these children exhibited severe motor disabilities, a pattern that differs from high-income countries, likely due to differences in risk factors and access to early interventions. The Fidgety Movements Assessment at 3–4 months corrected age demonstrated over 95% sensitivity and specificity for CP, confirming its diagnostic value in LMIC settings and aligning with findings from high-income countries.
When the two GMAs and HINE assessments were combined, the predictive results were remarkable, achieving 100% sensitivity for CP detection with no missed cases. Additionally, the protocol demonstrated strong predictive accuracy for other developmental delays in the non-cerebral palsy group, with motor sensitivity exceeding 86.9%, cognitive sensitivity over 86.7%, and social-emotional sensitivity above 83.3%. This highlights the protocol’s ability to identify children at risk for developmental delays beyond CP, making it a valuable tool in LMIC healthcare systems.
This study underscores how innovative adaptations can overcome resource limitations. Unlike high-income countries, where neuroimaging is routinely used for early CP detection, this modified method relies on simple, cost-effective, and scalable tools. The findings emphasise several key points: high sensitivity without reliance on advanced imaging, the enhanced predictive accuracy of combining multiple assessments, the protocol’s seamless integration into routine care, and the acceptable rate of overidentification, which ensures access to early developmental therapies for children who may benefit from intervention.
This Sri Lankan study presents a transformative model for LMICs, demonstrating that early detection is not a luxury but a feasible reality. By integrating GMAs and HINE into routine checkups, healthcare systems can achieve early detection and intervention for high-risk infants. The broader implication is a paradigm shift in early intervention strategies globally, highlighting that healthcare innovation is not solely dependent on cutting-edge technology but also on optimising existing resources to make a tangible impact on children’s lives. This cost-effective approach offers hope to countless children and families, setting an example for other LMICs facing similar challenges in early neurodevelopmental care.
ASNAC 2024 will be held through 1-4 March at Cinnamon Grand, Colombo, Sri Lanka.
© 2024 Association of Sri Lankan Neurologists. All rights reserved. | Designed and Developed by Pentacove
